Cytokines and Biologic Therapy in Patients with Inflammatory Bowel Diseases-Reference-Cited by-同舟云学术

Cytokines and Biologic Therapy in Patients with Inflammatory Bowel Diseases

Published:2021-12-01 Issue:4 Volume:12 Page:443-445
ISSN:2036-7422
Container-title:Gastroenterology Insights
language:en
Short-container-title:Gastroenterology Insights

Author:

Caviglia Gian Paolo^ORCID,Ribaldone Davide Giuseppe^ORCID,Nicolosi Aurora,Pellicano Rinaldo^ORCID

Abstract

Inflammatory bowel diseases (IBD) are chronic inflammatory disorders, including Crohns’ disease (CD) and ulcerative colitis (UC), both characterized by a clinical relapsing course and an immune-mediated pathogenesis [...]

Publisher

MDPI AG

Subject

Gastroenterology,Hepatology

Link

https://www.mdpi.com/2036-7422/12/4/42/pdf

Reference20 articles.

1. History of Inflammatory Bowel Diseases

2. Endoscopic Evaluation and Therapeutic Considerations of Small Bowel Crohn’s Disease

3. Mayo Endoscopic Score and Ulcerative Colitis Endoscopic Index Are Equally Effective for Endoscopic Activity Evaluation in Ulcerative Colitis Patients in a Real Life Setting

4. Serum zonulin in patients with inflammatory bowel disease: a pilot study

5. Evaluation of cytokine levels as putative biomarkers to predict the pharmacological response to biologic therapy in inflammatory bowel diseases

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world effectiveness and safety of vedolizumab induction therapy for ulcerative colitis: A prospective nationwide Polish observational study;Advances in Clinical and Experimental Medicine;2023-05-11

2. Development of an Inflammation-Triggered In Vitro “Leaky Gut” Model Using Caco-2/HT29-MTX-E12 Combined with Macrophage-like THP-1 Cells or Primary Human-Derived Macrophages;International Journal of Molecular Sciences;2023-04-18

3. Cytokine profile in patients with osteoarthritis after SARS-CoV-2 infection;Minerva Biotechnology and Biomolecular Research;2022-11

4. Plasma matrix metalloproteinases (MMP-2 and MMP-9) as prognostic biomarkers in coronary heart disease;Minerva Biotechnology and Biomolecular Research;2022-09